While a recent study reported that also the abrogation of TGF-β signalling in CD11c+ cells leads to the development of autoimmune disease [40], this seems unlikely in our system since recombination in CD4+ CD11c+ cells was very rare. The gene discussed is CD4; the disease is autoimmune disease.